Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances

Go back to Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
(NASDAQ: DARE) Delayed: 0.71 --0 (-0%)
Previous Close $0.71    52 Week High
Open $0.71    52 Week Low
Day High $0.71    P/E N/A 
Day Low $0.71    EPS
Volume 9,250       

(NASDAQ: DARE) Delayed: 0.71 --0 (-0%)
Previous Close $0.71    52 Week High
Open $0.71    52 Week Low
Day High $0.71    P/E N/A 
Day Low $0.71    EPS
Volume 9,250